---
title: "OrbusNeich Medical Group Holdings Limited (06929.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/06929.HK.md"
symbol: "06929.HK"
name: "OrbusNeich Medical Group Holdings Limited"
industry: "Health Care Supplies"
---

# OrbusNeich Medical Group Holdings Limited (06929.HK)

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Location | HK Market |
| Website | [orbusneich.com](https://orbusneich.com) |

## Company Profile

OrbusNeich Medical Group Holdings Limited, an investment holding company, engages in the manufacture, trading, sale, and marketing of medical devices/instruments for the treatment of coronary and peripheral vascular diseases. The company offers semi-compliant balloons and scoring balloons for pre-di...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-19T04:30:12.000Z

**Overall: B (0.33)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 4 / 12 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 11.08% |  |
| Net Profit YoY | 4.68% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.94 |  |
| Dividend Ratio | 6.83% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 3.03B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 1.31B |  |


**Multi Score**: B

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 10.41% | B |
| Profit Margin | 24.10% | A |
| Gross Margin | 66.90% | A |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 11.08% | B |
| Net Profit YoY | 4.68% | C |
| Total Assets YoY | 7.87% | B |
| Net Assets YoY | 10.26% | B |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 414.85% | C |
| OCF YoY | 11.08% | B |

#### Operating Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.39 | C |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 8.03% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - OrbusNeich Medical Group Holdings Limited",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "10.41%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "24.10%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "66.90%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "11.08%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "4.68%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "7.87%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "10.26%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "414.85%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "11.08%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "C",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.39",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "8.03%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | CONANT OPTICAL (HK.2276) | A | B | B | B | B | B |
| 02 | CIRC (HK.1763) | B | B | C | C | B | B |
| 03 | INT MEDICAL (HK.1501) | B | B | C | B | B | B |
| 04 | ORBUSNEICH (HK.6929) | B | B | C | A | C | B |
| 05 | WEIGAO GROUP (HK.1066) | B | C | C | B | C | C |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 9.49 | 1/12 | 11.64 | 10.37 | 9.64 |
| PB | 0.94 | 6/12 | 1.16 | 1.04 | 0.97 |
| PS (TTM) | 2.29 | 8/12 | 2.81 | 2.51 | 2.33 |
| Dividend Yield | 6.83% | 1/12 | 6.28% | 2.83% | 2.48% |

## Institutional View

### Analyst Rating Distribution

> As of 2025-08-17T16:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 2 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 3.66 |
| Highest Target | 6.80 |
| Lowest Target | 6.41 |

## References

- [Company Overview](https://longbridge.com/en/quote/06929.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/06929.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/06929.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.